Delivery Order SPE2DR25D6028-SPE2DR26FARRG
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,017.52 to AmerisourceBergen Drug Corp for the supply of Tranexamic 1000mg in quantities of 10 units. This non-set-aside, competitively awarded contract was issued on May 28, 2025, with an ultimate completion date of May 29, 2025, reflecting expedited delivery requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract employs...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,750.24 to AmerisourceBergen Drug Corp for the supply of Tranexamic 1,000 mg/100 mL in sodium chloride 100 mL vials. This competitively awarded, firm fixed-price contract was executed on July 30, 2025, with a completion deadline of July 31, 2025. The award carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,489.51 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Tranexamic 1,000 mg/100 mL in sodium chloride solution (100 mL). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 6, 2025, and performance at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $1,213.56 delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Tranexamic 1,000 mg/100 mL in sodium chloride solution (100 mL units). This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The order carries no set-aside designation and is scheduled for completion by...
- The Defense Logistics Agency awarded a delivery order valued at $7,406.72 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Tranexamic 1,000 mg/100mL sodium chloride solution in 100mL units. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, with an ultimate completion date of August 8, 2025. The work will be performed at the awardee's corporate office location in Conshohocken,...
- This is a $1,475.22 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as AmerisourceBergen). The delivery order is for the supply of 4564240390 - Tranexamic Acid 1,000 mg/10 ml 10 ml, a pharmaceutical product, in support of DLA Troop Support Medical's requirements. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an indefinite delivery...
- The Defense Logistics Agency awarded a $2,910.13 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Tranexamic 1,000 mg/100 mL-NaCl 100 mL, a hemostatic agent commonly used in military and medical settings to reduce bleeding. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Tranexamic 1,000 mg/100mL-NaCl 100mL, a pharmaceutical product used primarily for hemorrhage control and bleeding management in military and medical settings. This firm fixed price delivery order, valued at $1,023.95, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company. The order, valued at $4,603.22, is for the supply of 4,564,043,690 units of the medication Tranexamic Acid 1,000 mg/100 mL-Sodium Chloride 100 mL. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on September 3, 2025, for Tranexamic 1,000 mg/100ml-NaCl 100ml pharmaceutical supplies, with a ceiling value of $1,202.94 and firm fixed pricing. The delivery order is not set-aside and is scheduled for ultimate completion by September 4, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement for a critical...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARRGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,105.63 to AmerisourceBergen Drug Corp for the supply of Tranexamic 1000mg in quantities of 10 units. This firm fixed-price delivery order, issued on November 13, 2025, with an ultimate completion date of December 11, 2025, represents a non-competitive award to the prime contractor under an existing contract vehicle. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Tranexamic acid is a hemostatic medication critical for military medical applications, supporting combat casualty care and surgical procedures across the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 11/13/25 |